News
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.
WDAM on MSN9h
FDA approves twice-yearly injectable for HIV prevention; local agency weighs in on impact in the Pine BeltThe medical community has reached another milestone that could put an end to the decades-long HIV epidemic. The Food & Drug Administration approved Yeztugo (Lenacapavir) Wednesday It’s a twice-yearly ...
Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over ...
Although largely as expected by investors, BMO Capital says lenacapavir’s approval for prevention, now known as Yeztugo, marks “a major win for Gilead (GILD)” in driving meaningful growth in its ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback